Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS)
- PMID: 30409315
- DOI: 10.1016/j.oraloncology.2018.10.001
Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS)
Abstract
Objectives: (1) Report the patterns of cervical node positivity for HPV + oropharyngeal squamous cell carcinoma (OPSCC) treated with transoral robotic surgery (TORS) and a unilateral level II-IV node dissection. (2) Investigate the regional failure rate following this operation. (3) Report the rate of pharyngocutaneous fistula (PCF) formation intraoperatively and postoperatively following TORS/neck dissection.
Methods: Retrospective case series of 88 patients with HPV+ OPSCC treated with TORS and simultaneous neck dissection levels II-IV at the University of Washington from 2010 to 2016. Primary endpoints were PCF, regional recurrence, disease-free survival (DFS), and overall survival (OS).
Results: The overall frequency of cervical node positivity was 93%, with 84% in level IIa, 7% in IIb, 23% in III, and 13% in IV. Two patients developed PCF intraoperatively, repaired with a local digastric flap, and no postoperative PCF occurred. Sixteen patients (18%) received surgery alone, 49 patients (56%) received adjuvant radiation, and 23 patients (26%) underwent adjuvant chemoradiation. DFS at 2 years was 95% and OS at 2 years was 100%. No concerning level Ib nodes were identified preoperatively or during surgery, and no regional failures occurred in this location.
Conclusion: Our data suggests, in TORS for HPV+ OPSCC, neck dissection of levels II-IV accurately stages the neck pathologically and prevents regional recurrences, with adjuvant therapy when indicated, and survival outcomes are excellent. Single-staged operations did not result in any postoperative PCF. Avoiding dissection of level Ib with TORS oropharyngectomy limits morbidity to the marginal mandibular nerve and salivary function, and resulted in no postoperative fistulas with minimal reconstruction interventions.
Keywords: HPV+ oropharyngeal squamous cell carcinoma; Level Ib; Neck disease; Neck dissection; Pharyngocutaneous fistula; Regional failure; Survival outcomes; TORS; Transoral robotic surgery.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.Oral Oncol. 2024 May;152:106783. doi: 10.1016/j.oraloncology.2024.106783. Epub 2024 Apr 2. Oral Oncol. 2024. PMID: 38569317
-
Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.Laryngoscope. 2021 Dec;131(12):E2865-E2873. doi: 10.1002/lary.29659. Epub 2021 Jun 2. Laryngoscope. 2021. PMID: 34076275
-
Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.J Robot Surg. 2024 May 28;18(1):226. doi: 10.1007/s11701-024-01910-0. J Robot Surg. 2024. PMID: 38806847 Free PMC article.
-
Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: A systematic review and meta-analysis.Eur J Surg Oncol. 2020 Apr;46(4 Pt A):644-649. doi: 10.1016/j.ejso.2019.09.185. Epub 2019 Sep 25. Eur J Surg Oncol. 2020. PMID: 31627931
-
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.Head Neck. 2016 Sep;38(9):1299-309. doi: 10.1002/hed.24447. Epub 2016 Jun 22. Head Neck. 2016. PMID: 27330003 Review.
Cited by
-
Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.BMC Cancer. 2022 May 12;22(1):535. doi: 10.1186/s12885-022-09609-x. BMC Cancer. 2022. PMID: 35549914 Free PMC article.
-
Surgical margins in head and neck squamous cell carcinoma: A narrative review.Int J Surg. 2024 Jun 1;110(6):3680-3700. doi: 10.1097/JS9.0000000000001306. Int J Surg. 2024. PMID: 38935830 Free PMC article. Review.
-
Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know.Healthcare (Basel). 2024 May 14;12(10):1014. doi: 10.3390/healthcare12101014. Healthcare (Basel). 2024. PMID: 38786424 Free PMC article. Review.
-
Neck Dissection Timing in Transoral Robotic or Laser Microsurgery in Oropharyngeal Cancer: A Systematic Review.OTO Open. 2022 Oct 11;6(4):2473974X221131513. doi: 10.1177/2473974X221131513. eCollection 2022 Oct-Dec. OTO Open. 2022. PMID: 36247656 Free PMC article.
-
Treatment Options in Early Stage (Stage I and II) of Oropharyngeal Cancer: A Narrative Review.Medicina (Kaunas). 2022 Aug 4;58(8):1050. doi: 10.3390/medicina58081050. Medicina (Kaunas). 2022. PMID: 36013517 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources